SYDNEY--3 Jan--
ASTRAZENECA ANNOUNCES...
ALDERLEY PARK: AstraZeneca has announced submission of a supplemental New Drug Application to the US Food and Drug
SEVEN WONDERS...
ZURICH: The Chairman of a panel of leading architectural experts has announced the 21 world's landmark sites which will
AsiaNet is a consortium of leading news agencies distributing unedited, translated news releases for worldwide clients. Visit www.asianetnews.net for full-text versions.
ASTRAZENECA ANNOUNCES... ALDERLEY PARK: AstraZeneca has announced submission of a supplemental New Drug Application to the US Food and Drug Administration to seek approval for a new indication for SEROQUEL (quetiapine fumarate) for the treatment of patients with depressive episodes associated with bipolar disorder. http://www.astrazenecapressoffice.com http://www.dbsalliance.org/PDF/IntroBrochureC2.pdf http://www.dbsalliance.org/media/bipolarfacts.html SEVEN WONDERS... ZURICH: The Chairman of a
AstraZeneca Thailand Launches NCD Certification Programme to Enhance Chronic Disease Care
—
AstraZeneca Thailand, in collaboration with the General Practi...